Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1962 Jan;41(1):185–195. doi: 10.1172/JCI104462

TISSUE DISTRIBUTION OF C14 AFTER THE INTRAVENOUS INJECTION OF LABELED FREE FATTY ACIDS AND CHYLOMICRONS IN NEPHROTIC RATS*

Claude L Malmendier 1,†
PMCID: PMC289209  PMID: 14469012

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAXTER J. H., GOODMAN H. C. Nephrotoxic serum nephritis in rats. I. Distribution and specificity of the antigen responsible for the production of nephrotoxic antibodies. J Exp Med. 1956 Oct 1;104(4):467–485. doi: 10.1084/jem.104.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BORGSTROM B. Investigation on lipid separation methods. Separation of phospholipids from neutral fat and fatty acids. Acta Physiol Scand. 1952 Jun 6;25(2-3):101–110. doi: 10.1111/j.1748-1716.1952.tb00862.x. [DOI] [PubMed] [Google Scholar]
  3. BRAGDON J. H. Colorimetric determination of blood lipides. J Biol Chem. 1951 Jun;190(2):513–517. [PubMed] [Google Scholar]
  4. BRAGDON J. H., GORDON R. S., Jr Tissue distribution of C14 after the intravenous injection of labeled chylomicrons and unesterified fatty acids in the rat. J Clin Invest. 1958 Apr;37(4):574–578. doi: 10.1172/JCI103640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BRAGDON J. H. On the composition of chyle chylomicrons. J Lab Clin Med. 1958 Oct;52(4):564–570. [PubMed] [Google Scholar]
  6. DEWEY W. C. Vascular-extravascular exchange of II31 plasma proteins in the rat. Am J Physiol. 1959 Aug;197:423–431. doi: 10.1152/ajplegacy.1959.197.2.423. [DOI] [PubMed] [Google Scholar]
  7. DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FORBES A. L., CAMLIN J. A. Effects of storage on serum nonesterified fatty acid concentrations. Proc Soc Exp Biol Med. 1959 Oct-Dec;102:709–710. doi: 10.3181/00379727-102-25371. [DOI] [PubMed] [Google Scholar]
  9. GORDON R. S., Jr, CHERKES A. Unesterified fatty acid in human blood plasma. J Clin Invest. 1956 Feb;35(2):206–212. doi: 10.1172/JCI103265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HEYMANN W., HACKEL D. B. Hepatic and extrahepatic depot lipids in rats with experimental nephrotic hyperlipemia. Metabolism. 1957 Mar;6(2):169–174. [PubMed] [Google Scholar]
  11. LOSSOW W. J., CHAIKOFF I. L. Carbohydrate sparing of fatty acid oxidation. I. The relation of fatty acid chain length to the degree of sparing. II. The mechanism by which carbohydrate spares the oxidation of palmitic acid. Arch Biochem Biophys. 1955 Jul;57(1):23–40. doi: 10.1016/0003-9861(55)90173-9. [DOI] [PubMed] [Google Scholar]
  12. MARSH J. B., DRABKIN D. L. Experimental reconstruction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipemia. Metabolism. 1960 Oct;9:946–955. [PubMed] [Google Scholar]
  13. MARSH J. B., DRABKIN D. L. Metabolic channeling in experimental nephrosis. II. Lipide metabolism. J Biol Chem. 1955 Feb;212(2):633–639. [PubMed] [Google Scholar]
  14. MARSH J. B., DRABKIN D. L. Metabolic channeling in experimental nephrosis. V. Lipide metabolism in the early stages of the disease. J Biol Chem. 1958 Feb;230(2):1083–1091. [PubMed] [Google Scholar]
  15. McCALLA C., GATES H. S., Jr, GORDON R. S., Jr C1402 Excretion after the intravenous administration of albumin-bound palmitate-1-C14 to intact rats. Arch Biochem Biophys. 1957 Oct;71(2):346–351. doi: 10.1016/0003-9861(57)90044-9. [DOI] [PubMed] [Google Scholar]
  16. RADDING C. M., STEINBERG D. Studies on the synthesis and secretion of serum lipoproteins by rat liver slices. J Clin Invest. 1960 Oct;39:1560–1569. doi: 10.1172/JCI104177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. ROSENMAN R. H., FRIEDMAN M., BYERS S. O. The causal role of plasma albumin deficiency in experimental nephrotic hyperlipemia and hypercholesteremia. J Clin Invest. 1956 May;35(5):522–532. doi: 10.1172/JCI103305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. RUTSTEIN D. D., INGENITO E. F., REYNOLDS W. E. The determination of albumin in human blood plasma and serum; a method based on the interaction of albumin with an anionic dye-2(4'-hydroxybenzeneazo) benzoic acid. J Clin Invest. 1954 Feb;33(2):211–221. doi: 10.1172/JCI102887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. SAFFRAN J., KALANT N. Mechanisms of hyperlipemia in experimental nephrosis. J Clin Invest. 1959 Oct;38:1717–1724. doi: 10.1172/JCI103950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. SEIFTER J., BAEDER D. H. Lipemia clearing by hyaluronidase, hyaluronate, and desoxycorticosterone, and its inhibition by cortisone, stress, and nephrosis. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):709–713. doi: 10.3181/00379727-86-21209. [DOI] [PubMed] [Google Scholar]
  21. SPERRY W. M., WEBB M. A revision of the Schoenheimer-Sperry method for cholesterol determination. J Biol Chem. 1950 Nov;187(1):97–106. [PubMed] [Google Scholar]
  22. Stewart C. P., Hendry E. B. The phospholipins of blood. Biochem J. 1935 Jul;29(7):1683–1689. doi: 10.1042/bj0291683. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES